An allele in IRF5 has been reported as conferring an increased risk for inflammatory bowel diseases, systemic lupus erythematosus and MS, suggesting that there is a link between IRF5 and several autoimmune diseases [59], [141]. This evidence concerns the gene IRF5 and myeloid sarcoma.